Market Overview

26737
Articles
248K
Views

Hal Lindon

Benzinga Editor

August 21, 2015 4:02 PM
"A hazard ratio of 1.027 (slightly favoring the control group) with a log rank p-value of 0.90 (not statistically significant, N.S.) indicated that th ...
August 21, 2015 4:01 PM
Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of liver failure, today ...
July 01, 2015 2:53 PM
GE (NYSE: GE) was notified today that the Department of Justice has initiated court proceedings seeking to enjoin the sale of GE Appliances to Electr ...
June 02, 2015 9:06 AM
Document Security Systems, Inc. (NYSE MKT: DSS), (DSS), a leader in anti-counterfeiting and authentication solutions, provided an update on its operat ...
June 02, 2015 8:58 AM
Susquehanna Financial Group upgraded Anheuser-Busch Inbev (NYSE: BUD) to Positive rating early Tuesday. Pablo Zuanic, analyst for Susquehanna also i ...
April 27, 2015 12:06 PM
When asked in an exclusive Benzinga phone interview, Raymond James analyst said he does not see Tesla as an future utilities play. However, he sees la ...
April 14, 2015 4:06 PM
Today, Biogen (NASDAQ: BIIB) announced detailed results from the Phase 2 RENEW study of anti-LINGO-1 in acute optic neuritis (AON) – the first clin ...
April 07, 2015 5:57 PM
Gilead Sciences, Inc. (NASDAQ: GILD) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) ...
February 26, 2015 3:15 PM
Gilead Sciences, Inc. (NASDAQ: GILD) today announced results from a Phase 3 study, ION-4, evaluating the once-daily single tablet regimen Harvoni® ( ...
February 26, 2015 9:05 AM
SolarCity® (Nasdaq: SCTY) has created a fund expected to finance $750 million in residential solar projects with an investment from Google. The new f ...
February 26, 2015 9:03 AM
Barnes & Noble, Inc. (NYSE: BKS), today announced the filing of a Registration Statement with the U.S. Securities and Exchange Commission in order ...
February 26, 2015 8:35 AM
Bristol-Myers Squibb Company (NYSE: BMY) today announced data supporting the clinical development of BMS-955176, an investigational component designed ...
February 25, 2015 1:34 PM
SFX Entertainment, Inc. (Nasdaq: SFXE) ("SFX" or "the Company") today confirmed that it received a proposal from Robert F.X. Sillerman ("Sillerman"), ...
February 13, 2015 10:28 AM
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for AL ...

Get Benzinga's Newsletters

Benzinga Professional